{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T07:51:43Z","timestamp":1776844303633,"version":"3.51.2"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T00:00:00Z","timestamp":1686787200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.critrevonc.2023.104057","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T17:09:40Z","timestamp":1686848980000},"page":"104057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The mechanism investigation of mutation genes in liver and lung metastasis of colorectal cancer by using NGS technique"],"prefix":"10.1016","volume":"188","author":[{"given":"Kai","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunlong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahui","family":"Mi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hailong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caijuan","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenzhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2971-3800","authenticated-orcid":false,"given":"Pengfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.critrevonc.2023.104057_bib1","doi-asserted-by":"crossref","first-page":"6113","DOI":"10.3748\/wjg.v20.i20.6113","article-title":"Role of surgery in CRC liver metastases","volume":"20","author":"Akgul","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104057_bib2","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.3892\/or.2017.5531","article-title":"Current status and future perspectives on treatment of liver metastasis in CRC (Review)","volume":"37","author":"AL Bandar","year":"2017","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104057_bib3","doi-asserted-by":"crossref","first-page":"882","DOI":"10.21037\/jgo.2016.11.02","article-title":"Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with CRC: determination of frequency and distribution pattern","volume":"7","author":"Al-Shamsi","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104057_bib4","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s13046-019-1469-4","article-title":"PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin","volume":"38","author":"Bae","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.104057_bib5","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s00432-002-0394-6","article-title":"DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in CRC patients. Result of a 5-year prospective study","volume":"128","author":"Bazan","year":"2002","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.104057_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1001\/jama.2021.0106","article-title":"Diagnosis and treatment of metastatic CRC: a review","volume":"325","author":"Biller","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104057_bib7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1101\/gad.293449.116","article-title":"Oncogenic Kras drives invasion and maintains metastases in CRC","volume":"31","author":"Boutin","year":"2017","journal-title":"Genes Dev."},{"issue":"21","key":"10.1016\/j.critrevonc.2023.104057_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20215369","article-title":"BRAF-mutated CRC: clinical and molecular insights","volume":"20","author":"Caputo","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.critrevonc.2023.104057_bib9","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S1470-2045(15)00122-9","article-title":"FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic CRC: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study","volume":"16","author":"Cremolini","year":"2015","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104057_bib10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/bjs.11603","article-title":"Risk of CRC associated with BRCA1 and\/or BRCA2 mutation carriers: systematic review and meta-analysis","volume":"107","author":"Cullinane","year":"2020","journal-title":"Br. J. Surg."},{"issue":"34","key":"10.1016\/j.critrevonc.2023.104057_bib11","doi-asserted-by":"crossref","first-page":"55368","DOI":"10.18632\/oncotarget.10552","article-title":"Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients","volume":"7","author":"de Ridder","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104057_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Dagogo-Jack","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6892","key":"10.1016\/j.critrevonc.2023.104057_bib13","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104057_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036190","article-title":"The insulin receptor substrate 1 (IRS1) in intestinal epithelial differentiation and in CRC","volume":"7","author":"Esposito","year":"2012","journal-title":"PLOS One"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104057_bib15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/cge.13679","article-title":"Is BRCA2 involved in early onset CRC risk?","volume":"97","author":"Gay-Bellile","year":"2020","journal-title":"Clin. Genet"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104057_bib16","first-page":"491","article-title":"Reduced expression of EphA5 is associated with lymph node metastasis, advanced TNM stage, and poor prognosis in colorectal carcinoma","volume":"32","author":"Gu","year":"2017","journal-title":"Histol. Histopathol."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.104057_bib17","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1136\/gut.2006.095455","article-title":"BRAF mutation and gene methylation frequencies of colorectal tumours with microsatellite instability increase markedly with patient age","volume":"55","author":"Iacopetta","year":"2006","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104057_bib18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0304-3835(98)00257-2","article-title":"Ki-ras codon 12 point mutational activation in Hong Kong colorectal carcinoma patients","volume":"134","author":"KO","year":"1998","journal-title":"Cancer Lett."},{"issue":"17","key":"10.1016\/j.critrevonc.2023.104057_bib19","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1056\/NEJMoa1908075","article-title":"Encorafenib, binimetinib, and cetuximab in BRAF V600E-mutated CRC","volume":"381","author":"Kopetz","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"6349","key":"10.1016\/j.critrevonc.2023.104057_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104057_bib21","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1073\/pnas.1319551111","article-title":"Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer","volume":"111","author":"Lui","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104057_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036653","article-title":"KRAS, BRAF and PIK3CA mutations and the loss of PTEN expression in Chinese patients with CRC","volume":"7","author":"Mao","year":"2012","journal-title":"PLOS One"},{"issue":"10","key":"10.1016\/j.critrevonc.2023.104057_bib23","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1136\/gut.2010.211557","article-title":"Epidemiology, management and prognosis of CRC with lung metastases: a 30-year population-based study","volume":"59","author":"Mitry","year":"2010","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.104057_bib24","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0039-6109(02)00051-8","article-title":"Colorectal metastasis (liver and lung)","volume":"82","author":"Penna","year":"2002","journal-title":"Surg. Clin. North Am."},{"issue":"6 Suppl 2","key":"10.1016\/j.critrevonc.2023.104057_bib25","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1097\/JTO.0b013e3181dca330","article-title":"Reported outcome factors for pulmonary resection in metastatic CRC","volume":"5","author":"Pfannschmidt","year":"2010","journal-title":"J. Thorac. Oncol."},{"issue":"23","key":"10.1016\/j.critrevonc.2023.104057_bib26","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1002\/cncr.32163","article-title":"Targeted therapy for CRC metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic CRC","volume":"125","author":"Piawah","year":"2019","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.104057_bib27","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1053\/j.gastro.2009.12.065","article-title":"The chromosomal instability pathway in colon cancer","volume":"138","author":"Pino","year":"2010","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104057_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3892\/or.2021.7961","article-title":"Molecular features and gene expression signature of metastatic CRC (Review)","volume":"45","author":"Poturnajova","year":"2021","journal-title":"Oncol. Rep."},{"issue":"7387","key":"10.1016\/j.critrevonc.2023.104057_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature10868","article-title":"Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR","volume":"483","author":"Prahallad","year":"2012","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.critrevonc.2023.104057_bib30","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nrd4281","article-title":"Targeting RAS-ERK signalling in cancer: promises and challenges","volume":"13","author":"Samatar","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.104057_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1200\/JCO.20.02088","article-title":"Encorafenib plus cetuximab as a new standard of care for previously treated BRAFV600E-mutant metastatic CRC: updated survival results and subgroup analyses from the BEACON study","volume":"39","author":"Tabernero","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104057_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/1878-0261.12018","article-title":"Determinants of metastatic competency in CRC","volume":"11","author":"Tauriello","year":"2017","journal-title":"Mol. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104057_bib33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global cancer incidence and mortality rates and trends -- an update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.104057_bib34","first-page":"e153","article-title":"Effect of KRAS and BRAF mutations on survival of metastatic CRC after liver resection: a systematic review and meta-analysis","volume":"16","author":"Tosi","year":"2017","journal-title":"Clin. CRC"},{"issue":"20","key":"10.1016\/j.critrevonc.2023.104057_bib35","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1158\/1078-0432.CCR-14-0332","article-title":"Mismatch repair status and BRAF mutation status in metastatic CRC patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies","volume":"20","author":"Venderbosch","year":"2014","journal-title":"Clin. Cancer Res"},{"issue":"23","key":"10.1016\/j.critrevonc.2023.104057_bib36","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1001\/jama.2017.7105","article-title":"Effect of First-line chemotherapy combined with cetuximab or bevacizumab on overall survival in patients with KRAS wild-type advanced or metastatic CRC: a randomized clinical trial","volume":"317","author":"Venook","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.104057_bib37","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41591-021-01233-9","article-title":"Intratumoral heterogeneity in cancer progression and response to immunotherapy","volume":"27","author":"Vitale","year":"2021","journal-title":"Nat. Med."},{"issue":"19","key":"10.1016\/j.critrevonc.2023.104057_bib38","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1038\/s41388-020-1259-7","article-title":"Loss of the nuclear Wnt pathway effector TCF7L2 promotes migration and invasion of human CRC cells","volume":"39","author":"Wenzel","year":"2020","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.104057_bib39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13045-020-00991-2","article-title":"Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of CRC","volume":"13","author":"Zhao","year":"2020","journal-title":"J. Hematol. Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823001452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823001452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:48:38Z","timestamp":1760903318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842823001452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":39,"alternative-id":["S1040842823001452"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104057","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mechanism investigation of mutation genes in liver and lung metastasis of colorectal cancer by using NGS technique","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104057"}}